Haring-Layton MarDee has filed 4 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 49000 shares of Dare Bioscience, Inc. ($DARE) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Dare Bioscience, Inc. | $DARE | Haring-Layton MarDee | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 49000 | $0.00 | 49,000.0000 | 13,929,502 | 9999.99% | 0.35% |
| Sept. 4, 2025 | Dare Bioscience, Inc. | $DARE | Haring-Layton MarDee | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 57000 | $0.00 | 57,000.0000 | 9,030,386 | 9999.99% | 0.63% |
| Jan. 28, 2025 | Dare Bioscience, Inc. | $DARE | Haring-Layton MarDee | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 38000 | $0.00 | 38,000.0000 | 8,700,386 | 9999.99% | 0.44% |
| March 12, 2024 | Dare Bioscience, Inc. | $DARE | Haring-Layton MarDee | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 290000 | $0.00 | 290,000.0000 | 8,331,161 | 9999.99% | 3.48% |